MD, Chu Montpellier France
Dr. Magdalena Meszaros is a hospital practitioner specializing in hepato-gastroenterology and liver transplantation. She has been serving at Montpellier University Hospital (80%) and Narbonne Hospital (20%) since 2018. She also acts as a consultant for the Expert Service for Viral Hepatitis (Occitanie) since 2018. Her medical journey includes assistant specialist roles at CHU Montpellier and CH Narbonne, along with extensive residency training in France and Romania. With a strong background in liver diseases, inflammatory bowel diseases, and organ transplantation, she actively participates in clinical trials and medical research.
š Education
Dr. Meszaros earned her Doctor of Medicine degree from the University of Medicine and Pharmacy āIuliu HaČieganuā Cluj-Napoca, Romania, and the University of Medicine of Nantes, France (2004-2010). She completed a postgraduate diploma in Hepato-Gastroenterology (2010-2015) and obtained specialized DIUs in Chronic Intestinal Inflammatory Diseases (Lille, 2015) and Organ Transplantation (Paris Diderot 7, 2017).
š¼ Experience
She has been a hospital practitioner in hepato-gastroenterology at CHU Montpellier and CH Narbonne since 2018. Previously, she worked as an assistant specialist in hepato-gastroenterology (2015-2016) and completed medical residencies in hepato-gastroenterology in Montpellier (2014-2015) and gastroenterology/hepatology in Paris and Romania (2011-2015). Her expertise spans viral hepatitis, liver transplantation, and inflammatory bowel diseases.
š Awards & Honors
Dr. Meszaros has been recognized for her contributions to hepato-gastroenterology and liver transplantation. She has played a key role in multiple clinical trials and research projects in hepatology, including being a principal investigator in NASH, VHC, and CHC studies since 2016. She maintains an active presence in national and international research networks.
š¬ Research Focus
Her research centers on liver diseases, viral hepatitis, non-alcoholic steatohepatitis (NASH), chronic liver conditions, and organ transplantation. She has been involved in clinical trials across phases II-IV, exploring new treatments for hepatic conditions. With a commitment to advancing medical knowledge, she contributes significantly to hepato-gastroenterology research and clinical practice.
Conclusion
Dr. Magdalena Meszaros exhibits a strong clinical background and active involvement in research, making her a commendable candidate for the Best Researcher Award. Enhancing the impact and leadership aspects of her research could further elevate her candidacy.